S.S. (2014). Improved extraction of intracellular biogenic selenium nanoparticles and their specificity for cancer chemoprevention. Journal of Nanomedicine & Nanotechnology 5 (2): 194.71 Srivastava, N. and Mukhopadhyay, M. (2015). Green synthesis and structural characterization of selenium nanoparticles and assessment of their antimicrobial property. Bioprocess and Biosystems Engineering 38 (9): 1723–1730.
72 Sukhov, BG, Ganenko, TV, Pogodaeva, NN, et al. 2017, Agent with antitumor activity based on arabinogalactan nanocomposites with selenium and methods for prepariation of such nanobiocomposites, RU patent 2614363.
73 Tang, S., Wang, T., Jiang, M. et al. (2019). Construction of arabinogalactans/selenium nanoparticles composites for enhancement of the antitumor activity. International Journal of Biological Macromolecules 128: 444–451.
74 Tran, P. and Webster, T.J. (2008). Enhanced osteoblast adhesion on nanostructured selenium compacts for anti‐cancer orthopedic applications. International Journal of Nanomedicine 3 (3): 391–396.
75 Tran, P.A., Sarin, L., Hurt, R.H., and Webster, T.J. (2010). Differential effects of nanoselenium doping on healthy and cancerous osteoblasts in coculture on titanium. International Journal of Nanomedicine 5: 351–358.
76 Tran, P.A., O'Brien‐Simpson, N., Reynolds, E.C. et al. (2016). Low cytotoxic trace element selenium nanoparticles and their differential antimicrobial properties against S. aureus and E. coli. Nanotechnology 27 (4): 045101.
77 Trukhan, I.S., Dremina, N.N., Lozovskaya, E.A., and Shurygina, I.A. (2018). Assessment of potential cytotoxicity during vital observation at the BioStation CT. Acta Biomedica Scientifica 3 (6): 48–53.
78 Vekariya, K.K., Kaur, J., and Tikoo, K. (2013). Alleviating anastrozole induced bone toxicity by selenium nanoparticles in SD rats. Toxicology and Applied Pharmacology 268 (2): 212–220.
79 Villette, S., Bermano, G., Arthur, J.R., and Hesketh, J.E. (1998). Thyroid stimulating hormone and selenium supply interact to regulate selenoenzyme gene expression in thyroid cells (FRTL‐5) in culture. FEBS Letters 438 (1–2): 81–84.
80 Wadhwani, S.A., Gorain, M., Banerjee, P. et al. (2017). Green synthesis of selenium nanoparticles using Acinetobacter sp. SW30: optimization, characterization and its anticancer activity in breast cancer cells. International Journal of Nanomedicine 12: 6841–6855.
81 Wang, Y. and Fu, L. (2012). Forms of selenium affect its transport, uptake and glutathione peroxidase activity in the Caco‐2 cell model. Biological Trace Element Research 149 (1): 110–116.
82 Wang, H., Zhang, J., and Yu, H. (2007). Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: comparison with selenomethionine in mice. Free Radical Biology & Medicine 42 (10): 1524–1533.
83 Wang, T., Yang, L., Zhang, B., and Liu, J. (2010). Extracellular biosynthesis and transformation of selenium nanoparticles and application in H2O2 biosensor. Colloids and Surfaces B: Biointerfaces 80 (1): 94–102.
84 Wang, Y., Wang, J., Hao, H. et al. (2016). In vitro and in vivo mechanism of bone tumor inhibition by selenium‐doped bone mineral nanoparticles. ACS Nano 10 (11): 9927–9937.
85 Wu, H., Zhu, H., Li, X. et al. (2013). Induction of apoptosis and cell cycle arrest in A549 human lung adenocarcinoma cells by surface‐capping selenium nanoparticles: an effect enhanced by polysaccharide–protein complexes from Polyporus rhinocerus. Journal of Agricultural and Food Chemistry 61 (41): 9859–9866.
86 Xia, Y., Xu, T., Zhao, M. et al. (2018a). Delivery of doxorubicin for human cervical carcinoma targeting therapy by folic acid‐modified selenium nanoparticles. International Journal of Molecular Sciences 19: E3582.
87 Xia, Y., Chen, Y., Hua, L. et al. (2018b). Functionalized selenium nanoparticles for targeted delivery of doxorubicin to improve non‐small‐cell lung cancer therapy. International Journal of Nanomedicine 13: 6929–6939.
88 Xia, Y., Guo, M., Xu, T. et al. (2018c). siRNA‐loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy. International Journal of Nanomedicine 13: 1539–1552.
89 Xie, Q., Deng, W., Yuan, X. et al. (2018). Selenium‐functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect. European Journal of Pharmaceutics and Biopharmaceutics 122: 87–95.
90 Yang, X., Grailer, J.J., Pilla, S. et al. (2010). Tumor‐targeting, pH‐responsive, and stable unimolecular micelles as drug nanocarriers for targeted cancer therapy. Bioconjugate Chemistry 21 (3): 496–504.
91 Yang, F., Tang, Q., Zhong, X. et al. (2012). Surface decoration by Spirulina polysaccharide enhances the cellular uptake and anticancer efficacy of selenium nanoparticles. International Journal of Nanomedicine 7: 835–844.
92 Yang, L., Wang, W., Chen, J. et al. (2018). A comparative study of resveratrol and resveratrol‐functional selenium nanoparticles: inhibiting amyloid β aggregation and reactive oxygen species formation properties. Journal of Biomedical Materials Research Part A 106 (12): 3034–3041.
93 Yanhua, W., Hao, H., Li, Y., and Zhang, S. (2016). Selenium‐substituted hydroxyapatite nanoparticles and their in vivo antitumor effect on hepatocellular carcinoma. Colloids and Surfaces B: Biointerfaces 140: 297–306.
94 Yin, T., Yang, L., Liu, Y. et al. (2015). Sialic acid (SA)‐modified selenium nanoparticles coated with a high blood‐brain barrier permeability peptide‐B6 peptide for potential use in Alzheimer's disease. Acta Biomaterialia 25: 172–183.
95 Zeng, S., Ke, Y., Liu, Y. et al. (2018). Synthesis and antidiabetic properties of chitosan‐stabilized selenium nanoparticles. Colloids and Surfaces B: Biointerfaces 170: 115–121.
96 Zeng, D., Zhao, J., Luk, K.H. et al. (2019). Potentiation of in vivo anticancer efficacy of selenium nanoparticles by mushroom polysaccharides surface decoration. Journal of Agricultural and Food Chemistry 67 (10): 2865–2876.
97 Zhang, J.S., Gao, X.Y., Zhang, L.D., and Bao, Y.P. (2001). Biological effects of a nano red elemental selenium. BioFactors 15 (1): 27–38.
98 Zhang, J., Wang, H., Bao, Y., and Zhang, L. (2004). Nano red elemental selenium has no size effect in the induction of seleno‐enzymes in both cultured cells and mice. Life Sciences 75 (2): 237–244.
99 Zhang, J., Wang, X., and Xu, T. (2008). Elemental selenium at nano size (Nano‐Se) as a potential chemopreventive agent with reduced risk of selenium toxicity: comparison with se‐methylselenocysteine in mice. Toxicological Sciences 101 (1): 22–31.
100 Zhang, Y., Li, X., Huang, Z. et al. (2013). Enhancement of cell permeabilization apoptosis‐inducing activity of selenium nanoparticles by ATP surface decoration. Nanomedicine: Nanotechnology, Biology, and Medicine 9 (1): 74–84.
101 Zhang, J., Teng, Z., Yuan, Y. et al. (2018). Development, physicochemical characterization and cytotoxicity of selenium nanoparticles stabilized by beta‐lactoglobulin. International Journal of Biological Macromolecules 107 (Pt B): 1406–1413.
102 Zhao, S., Yu, Q., Pan, J. et al. (2017a). Redox‐responsive mesoporous selenium delivery of doxorubicin targets MCF‐7 cells and synergistically enhances its anti‐tumor activity. Acta Biomaterialia 54: 294–306.
103 Zhao, S.J., Wang, D.H., Li, Y.W. et al. (2017b). A novel selective VPAC2 agonist peptide‐conjugated chitosan modified selenium nanoparticles with enhanced anti‐type 2 diabetes synergy effects.
